GSE115395 enzalutamide LNCaP 2 v 5 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE115395_enzalutamide_LNCaP_2_v_5_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE115395_enzalutamide_LNCaP_2_v_5_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE115395_enzalutamide_LNCaP_2_v_5_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE115395_enzalutamide_LNCaP_2_v_5_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

long intergenic non-protein coding RNA 205

Gene

H3.7 histone (putative)

Gene

colorectal neoplasia differentially expressed

Gene

colorectal cancer associated 1

Gene

GUSB pseudogene 1

Gene

HOXC13 antisense RNA

Gene

family with sequence similarity 66 member B

Gene

GASK1B antisense RNA 1

Gene

TTC28 antisense RNA 1

Gene

SUCLG2 divergent transcript

  • Gene

    long intergenic non-protein coding RNA 205


  • Gene

    H3.7 histone (putative)


  • Gene

    colorectal neoplasia differentially expressed


  • Gene

    colorectal cancer associated 1


  • Gene

    GUSB pseudogene 1


  • Gene

    HOXC13 antisense RNA


  • Gene

    family with sequence similarity 66 member B


  • Gene

    GASK1B antisense RNA 1


  • Gene

    TTC28 antisense RNA 1


  • Gene

    SUCLG2 divergent transcript

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.